SCHEMBL5095696

SCHEMBL5095696

FC(F)=C(F)CCCCBr

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17688222 0.84 LMNA (0.30)
SCHEMBL51926 0.81
SCHEMBL8527939 0.78
SCHEMBL866856 0.73 GPR84 (0.39) TSHR
SCHEMBL866855 0.71
SCHEMBL8018734 0.71
SCHEMBL16499931 0.71 FOLH1 (0.43)
SCHEMBL10627690 0.71 CES2 (0.46) TSHR
SCHEMBL864873 0.69
SCHEMBL1268926 0.69 CES2 (0.48) TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112876858-A Organic polysilicone-fluorine composition and preparation method thereof 杭州之江新材料有限公司 2021-06-01 CN claimed
JP-3017087-A None JP disclosed
CN-115353579-B Anti-swelling amphoteric ion exchange resin, preparation method thereof, ion exchange membrane and application 国家电投集团氢能科技发展有限公司 2023-04-18 CN disclosed
CN-114361544-A Cross-linked proton exchange membrane and preparation method thereof 国家电投集团氢能科技发展有限公司 2022-04-15 CN disclosed
CN-114133477-A Ion exchange resin, preparation method thereof, ion exchange membrane and application thereof 国家电投集团氢能科技发展有限公司 2022-03-04 CN disclosed
CN-112876858-A Organic polysilicone-fluorine composition and preparation method thereof 杭州之江新材料有限公司 2021-06-01 CN disclosed
US-20080119493-A1 5,6-Dialkyl-7-Aminotriazolopyrimidines, their Preparation and their Use for Controlling Harmful Fungi, and Compositions Comprising these Compounds BASF AKTIENGESELLSCHAFT (DE) 2008-05-22 US disclosed
EP-1725563-A2 5,6-DIALKYL-7-AMINO-TRIAZOLOPYRIMIDINES, METHOD FOR THEIR PRODUCTION, THEIR USE FOR CONTROLLING PATHOGENIC FUNGI AND AGENTS CONTAINING SAID COMPOUNDS BASF AKTIENGESELLSCHAFT (DE) 2006-11-29 EP disclosed
WO-2005087770-A2 5,6-DIHYDROCARBYL-7-AMINO-TRIAZOLOPYRIMIDINES, METHOD FOR THEIR PRODUCTION, THEIR USE FOR CONTROLLING PATHOGENIC FUNGI AND AGENTS CONTAINING SAID COMPOUNDS BASF AKTIENGESELLSCHAFT (DE) 2005-09-22 WO disclosed
US-6908937-B2 Heterocyclic fluoroalkenyl thioethers (II) BAYER CROPSCIENCE AG (DE) 2005-06-21 US disclosed
US-6710045-B2 FOR CONTROLLING ANIMAL PESTS, IN PARTICULAR INSECTS, ARACHNIDS AND NEMATODES BAYER CROPSCIENCE AG (DE) 2004-03-23 US disclosed
US-20030207869-A1 Heterocyclic fluoroalkenyl thioethers (II) BAYER CROPSCIENCE AG (DE) 2003-11-06 US disclosed
US-20030187259-A1 Heterocylic fluoroalkenyl thioethers and the use thereof as pesticides (IV) BAYER CROPSCIENCE AG (DE) 2003-10-02 US disclosed
EP-1311497-A1 HETEROCYCLIC FLUOROALKENYL THIOETHERS AND THE USE THEREOF AS PESTICIDES (IV) Bayer CropScience AG (DE) 2003-05-21 EP disclosed
EP-1311496-A1 HETEROCYCLIC FLUOROALKENYL THIOETHERS AND THE USE THEREOF AS PESTICIDES (III) Bayer CropScience AG (DE) 2003-05-21 EP disclosed
EP-1303500-A1 HETEROCYCLIC FLUOROALKENYL THIOETHERS (II) Bayer Aktiengesellschaft (DE) 2003-04-23 EP disclosed
WO-2002006257-A1 HETEROCYCLIC FLUOROALKENYL THIOETHERS AND THE USE THEREOF AS PESTICIDES (III) BAYER CROPSCIENCE AG (DE) 2002-01-24 WO disclosed
WO-2002006259-A1 HETEROCYCLIC FLUOROALKENYL THIOETHERS AND THE USE THEREOF AS PESTICIDES (IV) BAYER CROPSCIENCE AG (DE) 2002-01-24 WO disclosed
WO-2002006256-A1 HETEROCYCLIC FLUOROALKENYL THIOETHERS (II) BAYER CROPSCIENCE AG (DE) 2002-01-24 WO disclosed
JP-H0317087-A ORGANOSILICON COMPOUND TOSHIBA SILICONE CO LTD 1991-01-25 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030207869-A1 Heterocyclic fluoroalkenyl thioethers (II) CYP2E1, CYP2S1, CYP1A1 TSHR 203/4885
US-20080119493-A1 5,6-Dialkyl-7-Aminotriazolopyrimidines, their Preparation and their Use for Controlling Harmful Fungi, and Compositions Comprising these Compounds DPM1, ALKBH5, DERA TSHR 3758/4885
US-20030187259-A1 Heterocylic fluoroalkenyl thioethers and the use thereof as pesticides (IV) DDT, CYP4F2, CYP4F3 TSHR 235/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.